Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Chemopreventive action of non-steroidal anti-inflammatory drugs in 9,10-dimethylbenzanthracene induced lung carcinogenesis in BALB/C mice: Expression of COX-1, COX-2 and Nf-κB

Ravi Kishore Saini, Sankar Nath Sanyal, Jasvinder Singh Bhatti

. 2018 ; 16 (4) : 320-327.

Language English Country Czech Republic

Document type Research Support, Non-U.S. Gov't

Non-steroidal anti-inflammatory drugs (NSAIDs) play an effective chemopreventive action against a variety of cancers. The present study aimed at targeting pro-inflammatory cyclooxygenase (COX) and NF-kB mediated inflammatory pathways in 9,10-dimethylbenzanthracene (DMBA) induced lung cancer in BALB/C mice and chemoprotective action of NSAIDs. Animals were divided into five groups and treated with NSAIDs, intratracheally, daily for a period of 18 weeks. Group 1 as control, received vehicle treatment; Group 2 received single dose of DMBA (10 mg/kg bw); Group 3, 4 and 5 besides DMBA treatment, also received Aspirin (60 mg/kg bw), Celecoxib (6.0 mg/kg bw) and Etoricoxib (0.6 mg/kg bw), respectively. DMBA induce DNA damage, apoptosis and expression of COX-1, COX-2 and NF-κB using immunofluorescence and blot analysis were done. The present study demonstrated the formation of micronuclei, over-expression of COX-2 and NF-κB in DMBA induced lung tumorigenesis and thereby suggesting a marked role of inflammation in the tumour progression. Results indicate the formation of micronuclei in DMBA group, which were significantly reduced in aspirin treated group, and totally absent in the celecoxib and etoricoxib groups. In conclusion, co-administration of etoricoxib and celecoxib has significantly reduced the inflammatory potential of the growing neoplasm in DMBA induced lung cancer in male BALB/C mice.

References provided by Crossref.org

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc18039894
003      
CZ-PrNML
005      
20190322162027.0
007      
ta
008      
181210s2018 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jab.2018.03.002 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Saini, Ravi Kishore $u Panjab University, Department of Biophysics, Chandigarh, India
245    10
$a Chemopreventive action of non-steroidal anti-inflammatory drugs in 9,10-dimethylbenzanthracene induced lung carcinogenesis in BALB/C mice: Expression of COX-1, COX-2 and Nf-κB / $c Ravi Kishore Saini, Sankar Nath Sanyal, Jasvinder Singh Bhatti
504    __
$a Literatura
520    9_
$a Non-steroidal anti-inflammatory drugs (NSAIDs) play an effective chemopreventive action against a variety of cancers. The present study aimed at targeting pro-inflammatory cyclooxygenase (COX) and NF-kB mediated inflammatory pathways in 9,10-dimethylbenzanthracene (DMBA) induced lung cancer in BALB/C mice and chemoprotective action of NSAIDs. Animals were divided into five groups and treated with NSAIDs, intratracheally, daily for a period of 18 weeks. Group 1 as control, received vehicle treatment; Group 2 received single dose of DMBA (10 mg/kg bw); Group 3, 4 and 5 besides DMBA treatment, also received Aspirin (60 mg/kg bw), Celecoxib (6.0 mg/kg bw) and Etoricoxib (0.6 mg/kg bw), respectively. DMBA induce DNA damage, apoptosis and expression of COX-1, COX-2 and NF-κB using immunofluorescence and blot analysis were done. The present study demonstrated the formation of micronuclei, over-expression of COX-2 and NF-κB in DMBA induced lung tumorigenesis and thereby suggesting a marked role of inflammation in the tumour progression. Results indicate the formation of micronuclei in DMBA group, which were significantly reduced in aspirin treated group, and totally absent in the celecoxib and etoricoxib groups. In conclusion, co-administration of etoricoxib and celecoxib has significantly reduced the inflammatory potential of the growing neoplasm in DMBA induced lung cancer in male BALB/C mice.
650    _2
$a nádory plic $x genetika $x imunologie $x prevence a kontrola $7 D008175
650    _2
$a chemoprofylaxe $7 D018890
650    12
$a antiflogistika nesteroidní $x aplikace a dávkování $x farmakologie $7 D000894
650    _2
$a zánět $x farmakoterapie $x imunologie $x patofyziologie $7 D007249
650    _2
$a inhibitory cyklooxygenasy $x aplikace a dávkování $x farmakologie $7 D016861
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a myši inbrední BALB C $7 D008807
650    _2
$a zvířata $7 D000818
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a anthraceny $x aplikace a dávkování $x farmakologie $7 D000873
650    _2
$a DNA $x účinky léků $7 D004247
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Sanyal, Sankar Nath $u Panjab University, Department of Biophysics, Chandigarh, India
700    1_
$a Bhatti, Jasvinder Singh $u Sri Guru Gobind Singh College, Department of Biotechnology, Chandigarh, 160019, India
773    0_
$t Journal of applied biomedicine $x 1214-021X $g Roč. 16, č. 4 (2018), s. 320-327 $w MED00012667
856    41
$u https://jab.zsf.jcu.cz/pdfs/jab/2018/04/09.pdf $y plný text volně přístupný
910    __
$a ABA008 $b B 2301 $c 1249 $y 4 $z 0
990    __
$a 20181210075422 $b ABA008
991    __
$a 20190322162356 $b ABA008
999    __
$a ok $b bmc $g 1357782 $s 1036956
BAS    __
$a 3
BMC    __
$a 2018 $b 16 $c 4 $d 320-327 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
LZP    __
$c NLK125 $d 20190322 $a NLK 2018-52/vt

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...